Education
About Us
Working with TipRanks
Follow Us
Verici Dx Plc (GB:VRCI)
:VRCI
VRCI Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.47p - 7.30p
Previous CloseN/A
Volume9.63K
Average Volume (3M)1.68M
Market Cap
£7.95M
Enterprise Value6.45M
Total Cash (Recent Filing)£7.01M
Total Debt (Recent Filing)£458.00K
Price to Earnings (P/E)―
Beta-0.75
Next Earnings
Sep 15, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding1,513,394,200
10 Day Avg. Volume3,191,481
30 Day Avg. Volume1,682,496
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Verici Dx Plc News
VRCI FAQ
What was Verici Dx Plc’s price range in the past 12 months?
Verici Dx Plc lowest share price was 0.47p and its highest was 7.30p in the past 12 months.
What is Verici Dx Plc’s market cap?
Verici Dx Plc’s market cap is £7.95M.
When is Verici Dx Plc’s upcoming earnings report date?
Verici Dx Plc’s upcoming earnings report date is Sep 15, 2025 which is in 38 days.
How were Verici Dx Plc’s earnings last quarter?
Verici Dx Plc released its earnings results on Jun 30, 2025. The company reported -0.014p earnings per share for the quarter, missing the consensus estimate of N/A by -0.014p.
Is Verici Dx Plc overvalued?
According to Wall Street analysts Verici Dx Plc’s price is currently Overvalued.
Does Verici Dx Plc pay dividends?
Verici Dx Plc does not currently pay dividends.
What is Verici Dx Plc’s EPS estimate?
Verici Dx Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Verici Dx Plc have?
Verici Dx Plc has 1,513,394,200 shares outstanding.
What happened to Verici Dx Plc’s price movement after its last earnings report?
Verici Dx Plc reported an EPS of -0.014p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Verici Dx Plc?
Currently, no hedge funds are holding shares in GB:VRCI
Company Description
Verici Dx Plc
Verici Dx plc, an immuno-diagnostics development company, focuses on the kidney transplantation market. The company develops prognostic and diagnostic tests for kidney transplant patients. Its in-development tests include Clarava, a pre-transplant prognosis test for the risk of early acute rejection; Tuteva, a post-transplant test that focuses on acute cellular rejection; and Protega, a liquid biopsy that aims to predict the risk of fibrosis and long-term graft failure. The company was incorporated in 2020 and is based in Penarth, the United Kingdom.
Technical Analysis
Genedrive
―
Proteome Sciences
―
BSF Enterprise PLC
―
Abingdon Health PLC
―
GENinCode UK Ltd.
―
Ownership Overview
0.67%
Insiders
0.02%
Mutual Funds
― Other Institutional Investors
99.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---